LABU:ARCA-Direxion Daily S&P Biotech Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 141.05

Change

0.00 (0.00)%

Market Cap

USD 0.28B

Volume

0.85M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is designed to measure the performance of a sub-industry or group of sub-industries determined based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.05%

Management Expense Ratio: 1.14 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

+1.62 (+5.09%)

USD 8.48B
QLD ProShares Ultra QQQ 0.95 %

+0.76 (+0.80%)

USD 5.39B
SSO ProShares Ultra S&P500 0.90 %

+0.83 (+0.97%)

USD 4.50B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

+5.69 (+1.47%)

USD 4.11B
UPRO ProShares UltraPro S&P500 0.92 %

+1.17 (+1.47%)

USD 3.53B
TECL Direxion Daily Technology Bull.. 1.17 %

+1.16 (+1.44%)

USD 2.51B
USD ProShares Ultra Semiconductors 0.95 %

+1.59 (+1.42%)

USD 0.86B
DPST Direxion Daily Regional Banks .. 1.02 %

+6.91 (+7.83%)

USD 0.77B
YINN Direxion Daily FTSE China Bull.. 1.02 %

+0.33 (+1.60%)

USD 0.71B
ROM ProShares Ultra Technology 0.95 %

+0.63 (+0.99%)

USD 0.61B

ETFs Containing LABU

ULTY Tidal Trust II 6.35 % 0.00 %

+0.21 (+1.92%)

USD 0.04B

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9,151.46% 97% N/A 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 9,151.46% 97% N/A 99% N/A
Trailing 12 Months  
Capital Gain 10,626.24% 97% N/A 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 10,626.24% 97% N/A 99% N/A
Trailing 5 Years  
Capital Gain 1,430.24% 94% A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 1,430.24% 94% A 98% N/A
Average Annual (5 Year Horizon)  
Capital Gain 37.66% N/A N/A 92% A
Dividend Return 37.75% N/A N/A 91% A-
Total Return 0.09% N/A N/A 2% F
Risk Return Profile  
Volatility (Standard Deviation) 677.52% N/A N/A 2% F
Risk Adjusted Return 5.57% N/A N/A 30% F
Market Capitalization 0.28B 86% B+ 58% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike